Mortality Benefits of Vitamin A Are Not Affected by Varying Frequency, Total Dose, or Duration of Supplementation
- PMID: 28513263
- DOI: 10.1177/0379572117696663
Mortality Benefits of Vitamin A Are Not Affected by Varying Frequency, Total Dose, or Duration of Supplementation
Abstract
Background: Although vitamin A supplementation reduces child mortality, it remains unclear whether dosing frequency, total dose, or duration modifies effectiveness.
Objective: Determine whether mortality effects of vitamin A vary by dosing frequency, total dose, or duration.
Methods: Meta-analysis of randomized controlled trials, identified by systematic review and expert opinion, utilizing relatively standard World Health Organization doses in children <5 years. Meta-regression evaluated whether mortality effects varied by dosing frequency, total dose, or supplementation duration.
Results: Identified 17 trials, including 1,180,718 children, mean (standard deviation [SD]) age 31.5 (15.4) months at baseline. Supplementation frequency ranged every 3 months-every 2 years, supplementation duration 4-60 months (mean = 15.4; SD = 12.8), and total dose 134,361-2,200,000 IU (mean = 667,132 IU; SD = 540,795). Compared with control, vitamin A reduced mortality 22% (95% confidence interval [CI] = 10-32; P = 0.002). This protective effect was not modified by increasing supplementation frequency (dose/year: relative risk [RR] = 1.02; 95% CI = 0.98-1.06; P = .22), total dose (per 200,000 IU: RR = 1.02; 95% CI = 0.97-1.06; P = .31), nor supplementation duration (per year: RR = 1.06; 95% CI = 0.97-1.15; P = 0.14). Multivariate meta-regression showed similar results. Sensitivity analyses excluding 1 controversial trial (Aswathi 2013) did not alter findings.
Conclusion: Results confirm benefits of vitamin A supplementation in children <5 years in nations with vitamin A deficiency, without influence of frequency, total dose, or dosing duration within ranges evaluated. These findings inform design and efficiency of vitamin A supplementation policies.
Similar articles
-
The effect of neonatal vitamin A supplementation on morbidity and mortality at 12 months: a randomized trial.Int J Epidemiol. 2016 Dec 1;45(6):2112-2121. doi: 10.1093/ije/dyw238. Int J Epidemiol. 2016. PMID: 27789674 Free PMC article. Clinical Trial.
-
Impact of nutrition education and mega-dose vitamin A supplementation on the health of children in Nepal.Bull World Health Organ. 1996;74(5):533-45. Bull World Health Organ. 1996. PMID: 9002334 Free PMC article. Clinical Trial.
-
Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality.J Infect Dis. 2006 Mar 15;193(6):860-71. doi: 10.1086/500366. Epub 2006 Feb 8. J Infect Dis. 2006. PMID: 16479521 Clinical Trial.
-
Vitamin A supplementation, infectious disease and child mortality: a summary of the evidence.Nestle Nutr Inst Workshop Ser. 2012;70:79-90. doi: 10.1159/000337445. Epub 2012 Aug 31. Nestle Nutr Inst Workshop Ser. 2012. PMID: 25825298 Review.
-
Vitamin A supplementation: implications for morbidity and mortality in children.J Infect Dis. 2000 Sep;182 Suppl 1:S122-33. doi: 10.1086/315921. J Infect Dis. 2000. PMID: 10944494 Review.
Cited by
-
Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.Cochrane Database Syst Rev. 2022 Mar 16;3(3):CD008524. doi: 10.1002/14651858.CD008524.pub4. Cochrane Database Syst Rev. 2022. PMID: 35294044 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical